SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Lightricks challenges AI giants with open-source text-to-video platform

Full list of Israeli high-tech funding rounds in 2024

TailorMed raises $40 million in equity and debt to help patients access critical medications

Why Israeli tech companies are moving to Miami

Buzz

Most popular

Daily

Weekly

1

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

2

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

3

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

4

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

5

Prompt Security raises $18 million Series A to protect enterprises from GenAI risks

Bristol-Myers Squib

1 stories about Bristol-Myers Squib

ענת כהן-דייג מנכ"לית קומפיוג'ן

Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen

12.10.18|Dror Reich

The investment is part of a clinical trial collaboration for a treatment that combines Compugen’s investigational antibody with an immune checkpoint inhibitor from Bristol-Myers Squibb